📰 David Drutz News
David Drutz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Drutz. Real-time updates on events, politics, business and more.
January 17, 2024
When Sasha Liknaitzky-Drutz and David Drutz of Toronto held their first soup-to-nuts Shabbat on Dec. 22, the guest of honor was 6,000 miles away. Now in their second year of marriage, the couple …
January 12, 2024
Within its first month, 85 households have kept Shabbat for the first time as part of the initiative, and more Shabbat first-timers are being matched with more soldiers each week.The
June 9, 2023
Altimmune, Inc. (NASDAQ:ALT – Get Rating) has earned an average recommendation of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month price objective among brokerages […]
May 22, 2023
Sectoral Asset Management Inc. grew its holdings in Altimmune, Inc. (NASDAQ:ALT – Get Rating) by 27.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 342,500 shares of the company’s stock after acquiring an additional 73,400 shares during the period. Sectoral Asset Management […]
May 22, 2023
Sectoral Asset Management Inc. increased its position in shares of Altimmune, Inc. (NASDAQ:ALT – Get Rating) by 27.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 342,500 shares of the company’s stock after acquiring an additional 73,400 shares during the quarter. Sectoral Asset Management Inc.’s holdings in Altimmune were worth $5,634,000 at the […]
May 17, 2023
Landscape Capital Management L.L.C. bought a new position in shares of Altimmune, Inc. (NASDAQ:ALT – Get Rating) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 28,975 shares of the company’s stock, valued at approximately $477,000. Landscape Capital Management L.L.C. owned 0.06% of Altimmune as […]
May 15, 2023
Shares of Altimmune, Inc. (NASDAQ:ALT – Get Rating) have earned a consensus rating of “Moderate Buy” from the eight brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year price target […]
May 13, 2023
Altimmune, Inc. (NASDAQ:ALT – Get Rating) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokers […]
April 20, 2023
Altimmune, Inc. (NASDAQ:ALT – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month target price among brokerages […]
April 1, 2023
JMP Securities reiterated their market outperform rating on shares of Altimmune (NASDAQ:ALT – Get Rating) in a report released on Friday, Benzinga reports. They currently have a $15.00 target price on the stock. Several other research analysts have also weighed in on the stock. Evercore ISI upped their price objective on shares of Altimmune from […]